Skip to content

SALVIA OFFICINALIS CALLUS LYSATE

83

Safety score · 0–100

Good

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A biotechnology-derived lysate from cultured common sage cells, offering standardized bioactive compounds without the variability of whole-plant extracts.

Salvia officinalis callus lysate is produced by lysing cultured plant callus cells, a controlled biotechnological process that yields consistent bioactive metabolites including rosmarinic acid, phenolic compounds, and flavonoids without seasonal variation. As a pure cell lysate with no known EU restrictions under Regulation 1223/2009, it presents a well-defined safety profile. No sensitization, mutagenicity, or toxicity concerns have been identified in available literature.

Skin benefits

  • High in rosmarinic acid providing potent antioxidant and anti-inflammatory effects
  • Standardized bioactive content free from lot-to-lot variation
  • Supports skin barrier function through nutrient-rich cellular contents

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find SALVIA OFFICINALIS CALLUS LYSATE in your products.

Scan any cosmetic product with LuxSense to see if it contains SALVIA OFFICINALIS CALLUS LYSATE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.